191 related articles for article (PubMed ID: 27338538)
1. Human leukocyte antigen-DR13 and DR15 are associated with short-term lung transplant outcomes.
Gracon AS; Liang TW; Rothhaar K; Wu J; Wilkes DS
J Surg Res; 2016 Jun; 203(1):82-90. PubMed ID: 27338538
[TBL] [Abstract][Full Text] [Related]
2. Specific Donor HLA-DR Types Correlate With Altered Susceptibility to Development of Chronic Lung Allograft Dysfunction.
Haynes LD; Julliard WA; Mezrich JD; Leverson G; Meyer KC; Burlingham WJ
Transplantation; 2018 Jul; 102(7):1132-1138. PubMed ID: 29360666
[TBL] [Abstract][Full Text] [Related]
3. HLA mismatches influence lung transplant recipient survival, bronchiolitis obliterans and rejection: implications for donor lung allocation.
Peltz M; Edwards LB; Jessen ME; Torres F; Meyer DM
J Heart Lung Transplant; 2011 Apr; 30(4):426-34. PubMed ID: 21145259
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation.
Chalermskulrat W; Neuringer IP; Schmitz JL; Catellier DJ; Gurka MJ; Randell SH; Aris RM
Chest; 2003 Jun; 123(6):1825-31. PubMed ID: 12796156
[TBL] [Abstract][Full Text] [Related]
5. The impact of HLA-DR mismatch status on retransplant-free survival and bronchiolitis obliterans syndrome‒free survival among sensitized lung transplant recipients.
Courtwright AM; Kamoun M; Kearns J; Diamond JM; Golberg HJ
J Heart Lung Transplant; 2020 Dec; 39(12):1455-1462. PubMed ID: 33071182
[TBL] [Abstract][Full Text] [Related]
6. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
[TBL] [Abstract][Full Text] [Related]
7. Epitope analysis of the collagen type V-specific T cell response in lung transplantation reveals an HLA-DRB1*15 bias in both recipient and donor.
Keller MR; Haynes LD; Jankowska-Gan E; Sullivan JA; Agashe VV; Burlingham SR; Burlingham WJ
PLoS One; 2013; 8(11):e79601. PubMed ID: 24265781
[TBL] [Abstract][Full Text] [Related]
8. De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation.
Morrell MR; Pilewski JM; Gries CJ; Pipeling MR; Crespo MM; Ensor CR; Yousem SA; D'Cunha J; Shigemura N; Bermudez CA; McDyer JF; Zeevi A
J Heart Lung Transplant; 2014 Dec; 33(12):1288-94. PubMed ID: 25443870
[TBL] [Abstract][Full Text] [Related]
9. Rapid detection of donor cell free DNA in lung transplant recipients with rejections using donor-recipient HLA mismatch.
Zou J; Duffy B; Slade M; Young AL; Steward N; Hachem R; Mohanakumar T
Hum Immunol; 2017 Apr; 78(4):342-349. PubMed ID: 28267558
[TBL] [Abstract][Full Text] [Related]
10. Expression of class II major histocompatibility complex antigens (HLA-DR) and lymphocyte subset immunotyping in chronic pulmonary transplant rejection.
Hasegawa S; Ockner DM; Ritter JH; Patterson GA; Trulock EP; Cooper JD; Wick MR
Arch Pathol Lab Med; 1995 May; 119(5):432-9. PubMed ID: 7748071
[TBL] [Abstract][Full Text] [Related]
11. Influence of human leukocyte antigen mismatching on bronchiolitis obliterans syndrome in lung transplantation.
Hayes D; Black SM; Tobias JD; Kopp BT; Kirkby SE; Mansour HM; Whitson BA
J Heart Lung Transplant; 2016 Feb; 35(2):186-94. PubMed ID: 26496787
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus antibody status of donor/recipient does not influence the incidence of bronchiolitis obliterans syndrome in lung transplantation.
Luckraz H; Sharples L; McNeil K; Wreghitt T; Wallwork J
J Heart Lung Transplant; 2003 Mar; 22(3):287-91. PubMed ID: 12633696
[TBL] [Abstract][Full Text] [Related]
13. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?
Moffatt-Bruce SD; Karamichalis J; Robbins RC; Whyte RI; Theodore J; Reitz BA
Ann Thorac Surg; 2006 Jan; 81(1):286-91; discussion 291. PubMed ID: 16368382
[TBL] [Abstract][Full Text] [Related]
14. Pre-transplant presence of antibodies to MICA and HLA class I or II are associated with an earlier onset of bronchiolitis obliterans syndrome in lung transplant recipients.
Lyu DM; Grazia TJ; Benson AB; Cagle LR; Freed BM; Zamora MR
Clin Transpl; 2012; ():237-46. PubMed ID: 23721028
[TBL] [Abstract][Full Text] [Related]
15. Improved long-term graft outcome in lung transplant recipients who have donor antigen-specific hyporeactivity.
Reinsmoen NL; Bolman RM; Savik K; Butters K; Matas AJ; Hertz MI
J Heart Lung Transplant; 1994; 13(1 Pt 1):30-6; discussion 36-7. PubMed ID: 7513186
[TBL] [Abstract][Full Text] [Related]
16. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome.
Sundaresan S; Mohanakumar T; Smith MA; Trulock EP; Lynch J; Phelan D; Cooper JD; Patterson GA
Transplantation; 1998 Mar; 65(5):648-53. PubMed ID: 9521198
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients.
Park JE; Kim CY; Park MS; Song JH; Kim YS; Lee JG; Paik HC; Kim SY
BMC Pulm Med; 2018 Mar; 18(1):45. PubMed ID: 29529999
[TBL] [Abstract][Full Text] [Related]
18. Mismatches at the HLA-DR and HLA-B loci are risk factors for acute rejection after lung transplantation.
Schulman LL; Weinberg AD; McGregor C; Galantowicz ME; Suciu-Foca NM; Itescu S
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1833-7. PubMed ID: 9620914
[TBL] [Abstract][Full Text] [Related]
19. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients.
Sacher VY; Fertel D; Srivastava K; Panos A; Nguyen D; Baxter T; Shafazand S; Pham SM
Ann Thorac Surg; 2014 Jan; 97(1):268-74. PubMed ID: 24119986
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of antibodies to lung self-antigens (Kα1 tubulin and collagen V) and donor specific antibodies to HLA in lung transplant recipients and implications for lung transplant outcomes: Single center experience.
Rao U; Sharma M; Mohanakumar T; Ahn C; Gao A; Kaza V
Transpl Immunol; 2019 Jun; 54():65-72. PubMed ID: 30794945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
